Back
Summit Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
SMMT
Summit Therapeutics
Last Price:
$26.37
Seasonality Move:
10.62%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight selling pressure.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.25 | Sell |
| 20-day SMA: | 25.91 | Buy |
| 50-day SMA: | 23.37 | Buy |
| 200-day SMA: | 21.31 | Buy |
| 8-day EMA: | 10.55 | Buy |
| 20-day EMA: | 4.84 | Buy |
| 50-day EMA: | 2.05 | Buy |
| 200-day EMA: | 0.53 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.77 | Buy |
| Relative Strength Index (14 RSI): | 55.6 | Buy |
| Chaikin Money Flow: | -1484038 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.46 - 27.46) | Buy |
| Bollinger Bands (100): | (19.38 - 26.4) | Buy |
Summit Therapeutics Technical Analysis
| Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 26.66 while SMMT 8-day simple moving average is 27.25, which is a Sell signal.
-
The stock price of SMMT is 26.66 while Summit Therapeutics 20-day SMA is 25.91, which makes it a Buy.
-
Summit Therapeutics 50-day simple moving average is 23.37 while SMMT share price is 26.66, making it a Buy technically.
-
SMMT stock price is 26.66 and Summit Therapeutics 200-day simple moving average is 21.31, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
37
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a SellThe current Summit Therapeutics [SMMT] share price is $26.66. The Score for SMMT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics Stock Info
Market Cap:
19.8B
Price in USD:
26.66
Share Volume:
3.4M
Summit Therapeutics 52-Week Range
52-Week High:
36.91
52-Week Low:
8.88
Sell
37
Summit Therapeutics (SMMT)
is a Sell
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?The Summit Therapeutics stock price is 26.66 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is overvalued.
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 26.66 while SMMT 8-day exponential moving average is 10.55, which is a Buy signal.
-
The stock price of SMMT is 26.66 while Summit Therapeutics 20-day EMA is 4.84, which makes it a Buy.
-
Summit Therapeutics 50-day exponential moving average is 2.05 while SMMT share price is 26.66, making it a Buy technically.
-
SMMT stock price is 26.66 and Summit Therapeutics 200-day simple moving average is 0.53, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is 3.77, suggesting Summit Therapeutics is a Buy
-
Summit Therapeutics Relative Strength Index (RSI) is 55.6, which suggest Summit Therapeutics is overbought
-
The Bollinger Bands (25) for Summit Therapeutics is (22.46 - 27.46), which suggest Summit Therapeutics is a Buy
-
The Bollinger Bands (100) for Summit Therapeutics is (19.38 - 26.4), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.